Viewing Study NCT03407105


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-07-06 @ 1:54 AM
Study NCT ID: NCT03407105
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2018-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MDX010-10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View